• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Cardiology

Sensitive cardiac injury marker could reduce stress testing for myocardial ischemia

byCaitlyn HuiandDeepti Shroff, DMD, MS
November 12, 2018
in Cardiology, Chronic Disease
Reading Time: 2 mins read
Reperfusion therapy may be suboptimal for STEMIs requiring transfers
Share on FacebookShare on TwitterShare on LinkedIn

1. The authors of this study found that low levels of high-sensitivity cardiac troponin I may be a useful measurement to rule out inducible myocardial ischemia among patients with stable coronary artery disease (CAD).

2. In this study’s three year-follow up, no adverse effects were observed for patients with low levels of high-sensitivity cardiac troponin I.

Evidence Rating Level: 2 (Good)

Study Rundown: Currently, patients with CAD may undergo routine surveillance stress testing. This testing is often costly and overused. Furthermore, current guidelines recommend against routine stress testing in patients with stable ischemic CAD, unless the purpose of the test is to assess new or progressive symptoms in patients. The authors of this study aimed to determine whether another measurement, low levels of resting high-sensitivity cardiac troponin I, could identify persons without inducible myocardial ischemia. Generally, they found that this marker could reduce stress testing for myocardial ischemia. The limitations of this study included that data may not be applicable to patients without known CAD. Furthermore, a larger cohort study would be important to validate results.

Click to read the study in the Annals of Internal Medicine

Relevant Reading: The utility of troponin measurement to detect myocardial infarction: review of the current findings

RELATED REPORTS

AI health chatbot shows no benefit for perinatal anxiety or depression

ADCE-D01 showed a 30% objective response rate in topline phase 1 results for previously treated advanced soft tissue sarcoma

In-Depth [observational study]: The authors conducted an observational cohort study that assessed the relationship between low levels of resting high-sensitivity cardiac troponin I and identifying persons without inducible myocardial ischemia. A total of 589 patients with stable CAD were included in the derivation group and 118 in the validation cohort. The mean age of patients in the derivation cohort was 63 years (SD, 9). The majority of patients were asymptomatic, with no chest pain (72%). Furthermore, in the derivation cohort, 10 out of 101 patients with a high-sensitivity cardiac troponin I level below 2.5pg/mL were found to have inducible myocardial ischemia (NPV, 90% [95% CI, 83% to 95%]). In comparison, 4 out of 32 patients in the validation cohort with high-sensitivity cardiac troponin below 2.5 pg/mL had inducible ischemia (NPV, 88% [CI, 71% to 96%]). Generally, the authors observed that for patients with stable CAD, low levels of the high-sensitivity cardiac troponin I had a high negative predictive value for ruling out inducible myocardial ischemia with stress testing. Furthermore, they found that in follow-up of the derivation cohort, there were no adverse events in patients with levels below 2.5 pg/mL over a median of 3 years. In contrast, for patients with levels of 2.5 pg/mL or greater, the authors observed 33 (7%) cardiovascular deaths or myocardial infarctions. 

Image: PD

©2018 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Previous Post

Inhaled inorganic nitrites do not improve exercise capacity in heart failure with preserved ejection fraction

Next Post

Symptom improvement after concussion in pediatric patients expected within four weeks

RelatedReports

Depression care collage: a calm woman in a linen shirt beside an empty speech bubble, a steaming teacup and a paper sunrise
Artificial Intelligence

AI health chatbot shows no benefit for perinatal anxiety or depression

November 20, 2026
Soft tissue sarcoma collage: arm muscles with an oval outlined in dotted teal, brass calipers and a folded surgical cap
2MM Trial Briefs

ADCE-D01 showed a 30% objective response rate in topline phase 1 results for previously treated advanced soft tissue sarcoma

November 20, 2026
Teen smartphone use collage: a teenage boy in a hoodie looking down at a phone, with empty speech bubbles rising from it
All Specialties

Less social media usage is associated with improved internalizing symptoms in high-risk young adults.

November 19, 2026
Physical activity collage: an engraved bicycle, a water bottle lying on its side and a path of flat stepping stones
Artificial Intelligence

AI cardiac MRI analysis marginally outperforms clinicians in predicting all-cause mortality

November 19, 2026
Next Post
Pre-operative transcranial magnetic stimulation useful for language mapping

Symptom improvement after concussion in pediatric patients expected within four weeks

The U.S. leads developed nations in premature deaths from drug overdose

The U.S. leads developed nations in premature deaths from drug overdose

Risk stratification criteria demonstrate high sensitivity for invasive bacterial infections among febrile infants

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • AI health chatbot shows no benefit for perinatal anxiety or depression
  • ADCE-D01 showed a 30% objective response rate in topline phase 1 results for previously treated advanced soft tissue sarcoma
  • Less social media usage is associated with improved internalizing symptoms in high-risk young adults.
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.